Ituxredi (rituximab biosimilar) - Dr. Reddy’s, Abbott, EMD Serono, CinnaGen, Fresenius Kabi, R-Pharm
Acvybra (denosumab biosimilar) - Alvotech, Dr. Reddy’s, Fuji Pharma
https://scanx.trade/stock-market-news/stocks/dr-reddy-s-laboratories-delays-us-biosimilar-launch-timeline-due-to-regulatory-processes/30597856
 
Jan 22, 2026
 
Next